Metabolic alterations in the sera of Chinese patients with mild persistent asthma: A GC-MS-based metabolomics analysis

Acta Pharmacologica Sinica

Volumn 36, Issue 11, 2015, Pages 1356-1366

  Chang, Chun ^a   Guo, Zhi Guo ^a   He, Bei ^a   Yao, Wan Zhen ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

Chinese patients; GC MS; inosine; metabolomics; mild persistent asthma; serum metabolites; succinate

Indexed keywords

3 AMINO 2 METHYLPROPIONIC ACID; 4 METHYLCATECHOL; 5 AMINOVALERIC ACID; ACID; ARACHIDONIC ACID; ASCORBIC ACID; ASPARAGINE; CITRULLINE; COENZYME A; COLECALCIFEROL; DEHYDROASCORBIC ACID; GLUTAMIC ACID; GLUTAMINE; GLYCEROL 2 PHOSPHATE; GLYCEROL OLEATE; HYDROXYPROLINE; INOSINE; LEVULINIC ACID; MALEAMATE; MALEIC ACID; ORNITHINE; PHENYLALANINE; PROTOCATECHUIC ACID; PYRROLE 2 CARBOXYLIC ACID; PYRUVATE OXIDASE; RIBOSE; SALICYLIC ACID; SUCCINIC ACID; THREONIC ACID; UNCLASSIFIED DRUG; UREA; HYDROXYBENZOIC ACID DERIVATIVE;

ADULT; AGED; AMINO ACID METABOLISM; ARTICLE; BLOOD SAMPLING; CARBOHYDRATE METABOLISM; CHINESE; CITRIC ACID CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HYPOXIA; MALE; MASS FRAGMENTOGRAPHY; METABOLISM; METABOLITE; METABOLOMICS; MILD PERSISTENT ASTHMA; NITROGEN METABOLISM; PREDICTIVE VALUE; TIME OF FLIGHT MASS SPECTROMETRY; UPREGULATION; UREA CYCLE; ASTHMA; BLOOD; CHINA; METABOLOME; MIDDLE AGED; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ASTHMA; CHINA; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; HYDROXYBENZOATES; INOSINE; MALE; METABOLIC NETWORKS AND PATHWAYS; METABOLOME; METABOLOMICS; MIDDLE AGED; PHENYLALANINE; SUCCINIC ACID;

EID: 84946542228     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2015.102     Document Type: Article

References (44)

1. Adamko DJ, Sykes BD, Rowe BH. The metabolomics of asthma: novel diagnostic potential. Chest 2012; 141: 1295-302.
2. Leung TF, Ko FW, Wong GW. Recent advances in asthma biomarker research. Ther Adv Respir Dis 2013; 7: 297-308.
3. Carraro S, Giordano G, Reniero F, Carpi D, Stocchero M, Sterk PJ, et al. Asthma severity in childhood and metabolomic profiling of breath condensate. Allergy 2013; 68: 110-7.
4. Holgate ST. Pathogenesis of asthma. Clin Exp Allergy 2008; 38: 872-97.
5. Green RH, Brightling CE, Bradding P. The reclassification of asthma based on subphenotypes. Curr Opin Allergy Clin Immunol 2007; 7: 43-50.
6. Holgate ST. The airway epithelium is central to the pathogenesis of asthma. Allergol Int 2008; 57: 1-10.
7. Fixman ED, Stewart A, Martin JG. Basic mechanisms of development of airway structural changes in asthma. Eur Respir J 2007; 29: 379-89.
8. Saude EJ, Skappak CD, Regush S, Cook K, Ben-Zvi A, Becker A, et al. Metabolomic profiling of asthma: diagnostic utility of urine nuclear magnetic resonance spectroscopy. J Allergy Clin Immunol 2011; 127: 757-64.
9. Atzei A, Atzori L, Moretti C, Barberini L, Noto A, Ottonello G, et al. Metabolomics in paediatric respiratory diseases and bronchiolitis. J Matern Fetal Neonatal Med 2011; 24: 59-62.
10. Dunn WB, Broadhurst D, Begley P, Zelena E, Francis-McIntyre S, Anderson N, et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc 2011; 6: 1060-83.
11. Fatemi F, Sadroddiny E, Gheibi A, Mohammadi Farsani T, Kardar GA. Biomolecular markers in assessment and treatment of asthma. Respirology 2014; 19: 514-23.
12. Carraro S, Rezzi S, Reniero F, Heberger K, Giordano G, Zanconato S, et al. Metabolomics applied to exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med 2007; 175: 986-90.
13. Fiehn O. Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks. Comp Funct Genomics 2001; 2: 155-68.
14. Snowden S, Dahlen SE, Wheelock CE. Application of metabolomics approaches to the study of respiratory diseases. Bioanalysis 2012; 4: 2265-90.
15. Nicholson JK, Connelly J, Lindon JC, Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 2002; 1: 153-61.
16. Bogdanov M, Matson WR, Wang L, Matson T, Saunders-Pullman R, Bressman SS, et al. Metabolomic profiling to develop blood biomarkers for Parkinson's disease. Brain 2008; 131: 389-96.
17. Saito K, Matsuda F. Metabolomics for functional genomics, systems biology, and biotechnology. Annu Rev Plant Biol 2010; 61: 463-89.
18. Wu H, Liu T, Ma C, Xue R, Deng C, Zeng H, et al. GC/MS-based metabolomic approach to validate the role of urinary sarcosine and target biomarkers for human prostate cancer by microwave-assisted derivatization. Anal Bioanal Chem 2011; 401: 635-46.
19. Sofia M, Maniscalco M, de Laurentiis G, Paris D, Melck D, Motta A. Exploring airway diseases by NMR-based metabonomics: a review of application to exhaled breath condensate. J Biomed Biotechnol 2011; 2011: 403260.
20. Motta A, Paris D, D'Amato M, Melck D, Calabrese C, Vitale C, et al. NMR metabolomic analysis of exhaled breath condensate of asthmatic patients at two different temperatures. J Proteome Res 2014; 13: 6107-20.
21. Ubhi BK, Riley JH, Shaw PA, Lomas DA, Tal-Singer R, MacNee W, et al. Metabolic profiling detects biomarkers of protein degradation in COPD patients. Eur Respir J 2012; 40: 345-55.
22. Jung J, Kim SH, Lee HS, Choi GS, Jung YS, Ryu DH, et al. Serum metabolomics reveals pathways and biomarkers associated with asthma pathogenesis. Clin Exp Allergy 2013; 43: 425-33.
23. Mattarucchi E, Baraldi E, Guillou C. Metabolomics applied to urine samples in childhood asthma; differentiation between asthma phenotypes and identification of relevant metabolites. Biomed Chromatogr 2012; 26: 89-94.
24. Wetmore DR, Joseloff E, Pilewski J, Lee DP, Lawton KA, Mitchell MW, et al. Metabolomic profiling reveals biochemical pathways and biomarkers associated with pathogenesis in cystic fibrosis cells. J Biol Chem 2010; 285: 30516-22.
25. Qiu Y, Cai G, Su M, Chen T, Zheng X, Xu Y, et al. Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLCQTOFMS. J Proteome Res 2009; 8: 4844-50.
26. Chen T, Xie G, Wang X, Fan J, Qiu Y, Zheng X, et al. Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma. Mol Cell Proteomics 2011; 10: M110.004945.
27. Kind T, Wohlgemuth G, Lee do Y, Lu Y, Palazoglu M, Shahbaz S, et al. FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry. Anal Chem 2009; 81: 10038-48.
28. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 2011; 12: 77.
29. Mukherjee AB, Zhang Z. Allergic asthma: influence of genetic and environmental factors. J Biol Chem 2011; 286: 32883-9.
30. Wheelock CE, Goss VM, Balgoma D, Nicholas B, Brandsma J, Skipp PJ, et al. Application of 'omics technologies to biomarker discovery in inflammatory lung diseases. Eur Respir J 2013; 42: 802-25.
31. Lisec J, Schauer N, Kopka J, Willmitzer L, Fernie AR. Gas chromatography mass spectrometry-based metabolite profiling in plants. Nat Protoc 2006; 1: 387-96.
32. Nordstrom A, Lewensohn R. Metabolomics: moving to the clinic. J Neuroimmune Pharmacol 2010; 5: 4-17.
33. Lloyd AJ, Beckmann M, Fave G, Mathers JC, Draper J. Proline betaine and its biotransformation products in fasting urine samples are potential biomarkers of habitual citrus fruit consumption. Br J Nutr 2011; 106: 812-24.
34. Walsh MC, Brennan L, Malthouse JP, Roche HM, Gibney MJ. Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans. Am J Clin Nutr 2006; 84: 531-9.
35. Pechlivanis A, Kostidis S, Saraslanidis P, Petridou A, Tsalis G, Mougios V, et al. 1H NMR-based metabonomic investigation of the effect of two different exercise sessions on the metabolic fingerprint of human urine. J Proteome Res 2010; 9: 6405-16.
36. Amaral AF. Metabolomics of asthma. J Allergy Clin Immunol 2014; 133: 1497-9.
37. Loureiro CC, Duarte IF, Gomes J, Carrola J, Barros AS, Gil AM, et al. Urinary metabolomic changes as a predictive biomarker of asthma exacerbation. J Allergy Clin Immunol 2014; 133: 261-3.
38. Fitzpatrick AM, Park Y, Brown LA, Jones DP. Children with severe asthma have unique oxidative stress-associated metabolomic profiles. J Allergy Clin Immunol 2014; 133: 258-61.
39. Eltzschig HK . Adenosine : anolddrug newly discovered . Anesthesiology 2009; 111: 904-15.
40. da Rocha Lapa F, de Oliveira AP, Accetturi BG, de Oliveira Martins I, Domingos HV, de Almeida Cabrini D, et al. Anti-inflammatory effects of inosine in allergic lung inflammation in mice: evidence for the participation of adenosine A2A and A3 receptors. Purinergic Signal 2013; 9: 325-36.
41. McClay JL, Adkins DE, Isern NG, O'Connell TM, Wooten JB, Zedler BK, et al. 1H Nuclear magnetic resonance metabolomics analysis identifies novel urinary biomarkers for lung function. J Proteome Res 2010; 9: 3083-90.
42. Bronte V, Zanovello P. Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol 2005; 5: 641-54.
43. Barnes PJ, Dweik RA, Gelb AF, Gibson PG, George SC, Grasemann H, et al. Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest 2010; 138: 682-92.
44. Hatziagorou E, Tsanakas J. Assessment of airway inflammation with exhaled NO measurement. Hippokratia 2007; 11: 51-62.